Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
FDA gives priority to Roche skin cancer drug vismodegib
Pharma Times, UK
Wed, 11/9/11 - 12:07 pm
Roche
vismodegib
FDA
skin cancer
basal cell carcinoma
hedgehog pathway inhibitor
Study: Deal terms getting richer as pharmas stockpile antibody tech
Fierce Biotech
Tue, 11/8/11 - 11:06 am
antibodies
autoimmune disease
CNS
Roche
AstraZeneca
Bristol-Myers Squibb
Novartis
Pfizer
Merck
mAb
China Biotech Week In Review: Roche's China Strategy
Seeking Alpha
Sun, 11/6/11 - 12:43 pm
Roche
China National Biotechnology Group
Aslan
Alios BioPharma
ImmunoBiology Ltd
Healthgen Biotechnology
Roche Unit Didn't Follow Procedures To Prevent Drug Contamination; Galena Presents Positive NeuVax Clinical Results
Biomed Reports
Sun, 11/6/11 - 12:25 pm
Roche
Avastin
Galena Biopharma
NeuVax
breast cancer
Pharmasset Takes Lead in Race to Develop Hep C Therapy By Pill
TheStreet.com
Tue, 11/1/11 - 09:01 am
Pharmasset
hepatitis C
Ribavirin
Vertex
Abbott Laboratories
PSI-7977
JNJ
Roche
Bristol-Myers Squibb
Doctors Are Split On Avastin For Breast Cancer
Pharmalot
Thu, 10/27/11 - 11:12 am
breast cancer
physicians
Avastin
Roche
Taxol
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Roche
Anadys
hepatitis C
ANA773
Abbott Laboratories
Roche Seeks ‘Targeted Acquisitions,’ Not Abbott-Sized Deal
Bloomberg
Fri, 10/21/11 - 10:54 am
Severin Schwan
Roche
Abbott Laboratories
M&A
Pharma CEOs
Abbott May Be Doing The Right Thing At The Wrong Time
Seeking Alpha
Fri, 10/21/11 - 09:57 am
Abbott Laboratories
reorganization
Amgen
Biogen Idec
Bristol-Myers Squibb
GSK
JNJ
Boston Scientific
Medtronic
Pfizer
Roche
Pharmasset
Halozyme rallies on Herceptin drug study
Marketwatch
Tue, 10/18/11 - 10:34 am
Halozyme
Herceptin
Roche
breast cancer
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Anadys
Roche
Merck
JNJ
Achillion
M&A
Indenix
Bristol-Myers Squibb
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Roche
M&A
Anadys
hepatitis C
Pegasys
setrobuvir
Merck
Victrelis
RG7128
Pharmasset
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Mon, 10/17/11 - 09:27 am
Roche
M&A
Anadys
hepatitis C
Weak cancer meds, Tamiflu take bite out of Roche sales
Fierce Pharma
Thu, 10/13/11 - 11:36 am
Tamiflu
Roche
earnings
Roche spotlights PhI efficacy of Alzheimer's antibody
Fierce Biotech
Tue, 10/11/11 - 10:59 am
Roche
Alzheimer's disease
gantenerumab
Spanish Drugmakers Eye $7 Billion Sale of Bonds Backed by Unpaid Bills
Bloomberg
Tue, 10/4/11 - 01:30 pm
Spain
Novartis
Roche
Pfizer, Roche, Novartis lead the way for Big Pharma in Japan
Fierce Pharma
Fri, 09/30/11 - 12:03 pm
Japan
Pfizer
Roche
Novartis
Roche expects $10 billion sales for HDL drug
Yahoo/Reuters
Mon, 09/26/11 - 11:31 am
Roche
HDL therapy
Merck
dalcetrapib
Anacetrapib
Roche’s Vismodegib Meets Main Goal of Advanced Skin-Cancer Study
Bloomberg
Sat, 09/24/11 - 12:43 pm
vismodegib
Roche
basal cell carcinoma
skin cancer
Roche, Mylan Settle Patent Case Over Drug Xeloda
Bloomberg
Thu, 09/22/11 - 08:30 am
Mylan
Roche
patents
Xeloda
cancer
Pages
« first
‹ previous
…
88
89
90
91
92
93
94
95
96
…
next ›
last »